Y-Mabs Therapeutics Overview

Y-Mabs Therapeutics Gross Profit

Gross Profit analysis for YMAB.

Quarterly Gross Profit

$16.86M

↓ 14.76% YoY

As of Jun 30, 2025

Annual Gross Profit (TTM)

$71.88M

↓ 6.29% YoY

Trailing 12 months ending Jun 30, 2025

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin